Business Wire

Helical Fusion Signs Japan’s First Power Purchase Agreement for Fusion Energy with Aoki Super

8.12.2025 11:00:00 EET | Business Wire | Press release

Share

Helical Fusion Co., Ltd. (Headquarters: Tokyo, Japan; “Helical Fusion”), a company developing a commercially viable Helical Stellarator power plant under its “Helix Program”, has signed a Power Purchase Agreement (PPA) with Aoki Super Co., Ltd. (Headquarters: Aichi, Japan; “Aoki Super”), a major regional supermarket chain in central Japan.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207372064/en/

Takaya Taguchi (left), CEO of Helical Fusion Co., Ltd. , and Masayuki Kono (right) Managing Director and Head of Administration Division of Aoki Super Co., Ltd. at the press conference held on December 8, 2025

This marks the first fusion-energy PPA ever signed in Japan, representing a concrete step forward in the real-world adoption of fusion energy and signaling growing demand-side engagement in the emerging fusion energy value chain.

Significance of This Agreement

Fusion energy—generated by reproducing on Earth the same nuclear fusion reactions that power the sun—is widely expected as a high-efficiency, sustainable energy source. Since the concept was proposed in the 1930s, global attention has focused primarily on the scientific and technical challenges of realizing fusion. However, for fusion to become part of real-world energy infrastructure, the presence of customers willing to procure fusion-generated electricity and to integrate it into their long-term decarbonization strategies is essential.

Under the Helix Program, Helical Fusion begins with a simple premise: fusion must function as a reliable power source. Working backward from this goal, the company defined three non-negotiable requirements—steady-state operation, net electricity, and maintainability—and selected the Helical Stellarator as the only design capable of meeting all three with existing technology. Helical Fusion’s approach is grounded in over 60 years of Japanese national fusion research, enabling the company to outline a credible technical pathway to continuous, net-electricity operation.

The newly signed PPA demonstrates that this development plan has been concretely evaluated by a real electricity consumer: Aoki Super, which requires large amounts of electricity every day to operate its store networks. Both companies share the view that fusion energy can underpin environmentally responsible retail operations that support everyday life.

The agreement is also an important milestone for the Helix Program, whose distinctive strength lies in mobilizing Japan’s entire industrial value chain—from advanced manufacturing to end-users—to accelerate the realization of fusion energy.

About Aoki Super Co., Ltd.

Founded in 1941 and headquartered in Nagoya, Aoki Super operates 50 community-based supermarkets across Aichi Prefecture, Japan. As a food retailer operating electricity-intensive stores, the company views climate change—such as shifting agricultural production regions and rising seawater temperatures affecting marine resources—as a critical challenge.

In July 2025, as part of its long-term commitment to sustainability and environmental stewardship, Aoki Super made a strategic investment in Helical Fusion.

About Helical Fusion Co., Ltd.

Helical Fusion is a Japan-based fusion company developing the world’s first commercially viable, net-electricity fusion power plant, leveraging the Helical Stellarator and inheriting more than 60 years of national fusion research.

To date, Helical Fusion has raised JPY 5.2 billion (≈ USD 34 million) in equity funding, bringing its cumulative fundraising—including grants and loans—to approximately USD 38 million (≈ JPY 6.0 billion).

​​About the Helix Program

The Helix Program targets the launch of the world’s first commercially viable fusion power plant in the 2030s through its Fusion Pilot Plant, Helix KANATA. The program defines three essential requirements for commercially viable fusion power:

Steady-state operation: 24/7/365 stable performance

Net electricity output: generating more energy than it consumes

Maintainability: regular, efficient component maintenance

The Helical Stellarator is uniquely capable of meeting all three criteria with existing technologies. The Helix Program aims to be the world’s first initiative to realize all of these requirements by the 2030s.

Company Details

View source version on businesswire.com: https://www.businesswire.com/news/home/20251207372064/en/

Contacts

Media Contact
Email: contact@helicalfusion.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

The Opening of Jayasom Wellness Resort Advancing AMAALA’s Wellness Vision16.9.2026 15:23:00 EEST | Press release

Red Sea Global (RSG), the regenerative tourism developer, has opened Jayasom Wellness Resort AMAALA, bringing a distinctive holistic health offering to the destination. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260916231950/en/ Outdoor relaxation area at Jayasom Wellness Resort AMAALA, where serene design and sea-facing spaces create a setting for rest and renewal. Designed by Heah & Co., with interiors by Studio Carter, Jayasom Wellness Resort AMAALA is located on Triple Bay’s largest cove and comprises 153 keys alongside 24 residences. The resort forms part of AMAALA’s secluded wellness core on the Red Sea coast, where nature and hospitality come together in a setting designed for reflection and renewal. “As we launch the first Jayasom globally, we are bringing a new dimension to AMAALA’s wellness offering. Its dedicated, all-inclusive wellness retreats combine contemporary, evidence-based practices with Arab and East

Rubedo Life Sciences Announces Clinical Study to Treat Hair Loss with GPX4 Modulator RLS-1496, First Human Ex Vivo Evidence Demonstrates Robust Hair Follicle Growth16.9.2026 15:01:00 EEST | Press release

Rubedo Life Sciences, Inc. (Rubedo) today announced a new clinical study of investigational RLS-1496 in patients with androgenetic alopecia (AGA), beginning October 2026, with initial data expected in the first half of 2027. The study marks the first-ever clinical evaluation of a GPX4 modulator in hair loss, extending the program that established RLS-1496 as the world’s first GPX4 modulator to enter human clinical trials of any kind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260916811892/en/ Figure Legend: Representative images of intact ex vivo human hair follicles challenged with DHT 100 nM and stimulated with finasteride 600 nM (positive control) or RLS-1496 2000 nM at Days 0 and 6. RLS-1496 has already demonstrated efficacy in clinical trials for actinic keratoses and aging skin, and other skin conditions such as psoriasis and atopic dermatitis, generating novel human evidence demonstrating the dual SenoAdaptive mec

NetApp and Tampa Bay Buccaneers Partner to Enable Data-Driven Operational Excellence16.9.2026 15:00:00 EEST | Press release

NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced that they have been named an Official Partner of the Tampa Bay Buccaneers. This new relationship builds on NetApp’s status as the Official Intelligent Data Infrastructure Partner of the NFL, helping the league and its teams quickly and confidently access, manage, and activate their data. The Buccaneers will leverage NetApp technology to support the experience for Buccaneers fans in the stadium on game days and beyond. “NetApp will serve as a trusted technology partner that will help us elevate the customer experience for all Buccaneers fans,” said Buccaneers Chief Commercial Officer Atul Khosla. “Reliable and secure access to data plays an essential role in the overall game day experience at Raymond James Stadium. NetApp’s industry-leading intelligent data infrastructure will help us deliver a more seamless and connected experience for our Krewe at games and across the digital platforms that we use.” T

Unique Australian Clay: Multi Minerals Australia’s Non-antibiotic Solution for Poultry Production16.9.2026 14:44:00 EEST | Press release

Multi Minerals Australia, a leading mining company, announced a one-of-a-kind formulation of Australian clays which has proven it can reshape the global poultry feed economic landscape. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260916711777/en/ Unique, non-antibiotic clay stockfeed component and production enhancer from Multi Minerals Australia. Sourced from its one-of-a-kind geological deposit. Proven results. Worldwide distribution. Potential applications and lower cost benefits to a range of commercial animal production, particularly poultry. Expressions of interest sought. Numerous scientific, clinical, and commercial producer validations have demonstrated the product’s significant benefits; including the reduction of feed costs; improvements in: growth; meat yield; feed conversion; resistance to heat stress; eggshell quality and production: reduced inflammation and mortality in layer and broiler production. It has

Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 202616.9.2026 13:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026 and will participate in a fireside chat at 1:00pm ET. A live audio webcast of the fireside chat will be accessible at the following link: https://event.summitcast.com/view/fAK4ioHxQNLX5A2utMmqiy/2vkuNBQpn65oayAPDgU4rZ A replay of the webcast will be accessible for 30 days following each event at the “Events” page of the Investors section of the Compass website. About Compass Pathways We believe mental health patients deserve the possibility of a better future. Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye